Risk of mortality with drug coated balloon use in femoropopliteal disease
Sign Up to like & getrecommendations! Published in 2019 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.28423
Abstract: To the Editor: We read with interest a meta-analysis published in the catheterization and cardiovascular interventions titled––“Drug-coated balloon versus plain old balloon angioplasty in femoropopliteal disease: An updated meta-analysis of randomized controlled trials.” We would… read more here.
Keywords: risk mortality; coated balloon; balloon; drug coated ... See more keywords
Clinical implication of neointimal burden in in‐stent restenosis treated with drug‐coated balloon
Sign Up to like & getrecommendations! Published in 2020 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.29211
Abstract: Although drug‐coated balloon (DCB) angioplasty is a well‐established drug‐eluting stent (DES) in‐stent restenosis (ISR) strategy, there are minimal data regarding the association of neointimal burden on optical coherence tomography (OCT) before and after DCB and… read more here.
Keywords: neointimal burden; stent restenosis; drug; drug coated ... See more keywords
Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The VIVA REALITY study
Sign Up to like & getrecommendations! Published in 2021 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.29777
Abstract: Drug coated balloon (DCB) angioplasty significantly reduces reintervention rates in patients with symptomatic femoropopliteal peripheral artery disease (PAD). However, stand‐alone DCB use in long, severely calcified lesions is frequently associated with vessel recoil and/or high‐grade… read more here.
Keywords: atherectomy paclitaxel; angioplasty; disease; balloon ... See more keywords
Safety and efficacy of drug‐coated balloon for peripheral artery revascularization—A systematic review and meta‐analysis
Sign Up to like & getrecommendations! Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30074
Abstract: The relative merits of the drug‐coated balloon (DCB) versus uncoated balloon (UCB) angioplasty in endovascular intervention for patients with symptomatic lower extremity peripheral arterial disease (PAD) remains controversial. read more here.
Keywords: balloon; safety efficacy; coated balloon; drug coated ... See more keywords
Drug‐coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD study
Sign Up to like & getrecommendations! Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30472
Abstract: Whether the drug‐coated balloons (DCBs)‐alone strategy was superior to plain old balloon angioplasty (POBA) in treating SVD remains unknown. read more here.
Keywords: svd; balloon treatment; coated balloon; drug coated ... See more keywords
Drug‐coated balloon treatment of complex femoropopliteal disease yields favorable and durable outcomes at 5 years
Sign Up to like & getrecommendations! Published in 2022 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30500
Abstract: Randomized clinical trials (RCTs) of drug‐coated balloon (DCB) treatment of femoropopliteal (FP) disease compared to balloon angioplasty (PTA) have demonstrated superior outcomes. A meta‐ analysis of 13 RCTs and 9 registries demonstrated odds ratio of… read more here.
Keywords: balloon; femoropopliteal disease; coated balloon; drug coated ... See more keywords
Percutaneous coronary intervention with drug‐coated balloon‐only strategy combined with single antiplatelet treatment in patients at high bleeding risk: Single center experience of a novel concept
Sign Up to like & getrecommendations! Published in 2023 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30558
Abstract: At least 1 month of dual antiplatelet therapy is required after coronary stenting. The aim of this all‐comers retrospective registry study was to assess the efficacy and safety of percutaneous coronary intervention (PCI) using drug‐coated… read more here.
Keywords: percutaneous coronary; coated balloon; coronary intervention; drug coated ... See more keywords
Regulators can we get DCB balloons approved for use in the United States?
Sign Up to like & getrecommendations! Published in 2023 at "Catheterization and Cardiovascular Interventions"
DOI: 10.1002/ccd.30610
Abstract: We read with interest the recent paper written by Räsänen A. et al., entitled “Percutaneous Coronary Intervention with Drug‐Coated Balloon‐Only Strategy Combined with Single Antiplatelet Treatment in Patients at High Bleeding Risk–Single Center Experience of… read more here.
Keywords: restenosis; coated balloon; drug coated; treatment ... See more keywords
Paclitaxel-Coated Balloon Angioplasty in the Real World: Jack-of-all-Trades?
Sign Up to like & getrecommendations! Published in 2020 at "Cardiovascular and Interventional Radiology"
DOI: 10.1007/s00270-020-02731-y
Abstract: Efficacy of drug-coated balloon (DCB) angioplasty is well established for femoropopliteal lesions. However, clinical benefit differs considerably across DCB types [1]. Superiority of Passeo-18 lx DCB over standard balloon angioplasty (POBA) regarding the primary endpoint… read more here.
Keywords: dcb angioplasty; biolux iii; coated balloon; dcb ... See more keywords
A multicenter randomized comparison of paclitaxel-coated balloon with plain balloon angioplasty in patients with small vessel disease
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Research in Cardiology"
DOI: 10.1007/s00392-017-1126-x
Abstract: AimWe investigated the efficacy and safety of using paclitaxel-coated balloon (PCB) to treat small vessel disease.Methods and resultsIn this multicenter, prospective, randomized controlled trial, one-hundred and thirty-five patients with native coronary lesions in small vessels… read more here.
Keywords: group; paclitaxel coated; small vessel; pcb ... See more keywords
Twenty-four-month outcomes of drug-coated balloon in diabetic patients in the BIOLUX P-III registry: a subgroup analysis.
Sign Up to like & getrecommendations! Published in 2021 at "Annals of vascular surgery"
DOI: 10.1016/j.avsg.2021.02.050
Abstract: OBJECTIVES This study aims to assess the use of drug-coated balloon (DCB) in a large patient population under real-world conditions and, specifically, analyse the impact of diabetes mellitus on long term outcomes following DCB utilisation.… read more here.
Keywords: diabetic patients; coated balloon; subgroup analysis; drug coated ... See more keywords